NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-189-2016-0-FR-11 Mutant IDH1 Inhibitors Useful for Treating Cancer FR EP 17735296.0 Issued
NCATS E-189-2016-0-DE-09 Mutant IDH1 Inhibitors Useful for Treating Cancer DE EP 17735296.0 Issued
NCATS E-189-2016-0-PCT-02 Mutant IDH1 Inhibitors Useful for Treating Cancer PCT PCT PCT/US2017/038549 Expired
NCATS E-189-2016-0-CA-05 Mutant IDH1 Inhibitors Useful for Treating Cancer CA National Stage 3028999 Pending
NHGRI E-100-2017-0-US-01 Novel Codon-optimized And Tagged Human NPC1 Genes And AAV Vectors For The Treatment Of Niemann-Pick Type C1 Deficiency And Related Conditions US 62/522,677 Abandoned
NCI E-266-2011-0-AU-10 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage AU DIV 2017204103 Issued
NCI E-178-2017-0-US-01 Selective Bivalent Ligands Of The Polo-like Kinase 1 (Plk1) US 62/520,907 Abandoned
NICHD E-120-2015-0-HK-61 Method For On-demand Contraception HK EP 17105890.1 Abandoned
NCI E-172-2017-0-US-01 METHOD FOR DETERMINING LYMPHOMA TYPE US 62/519,728 Abandoned
NCATS E-230-2016-2-US-01 Tools To Develop A Therapy For The Treatment Of Zellweger Spectrum Disorder US CIP 15/623,333 Abandoned
NCI E-171-2017-0-US-01 LYMPHOMA TUMOR CLASSIFICATION AND SUSCEPTIBILITY TO INHIBITORS US 62/518,994 Abandoned
NCI E-242-2015-1-CN-08 Peptide-Based Methods For Treating Pancreatic Cancer CN National Stage 201580067961.7 Pending
NCATS E-050-2012-0-US-11 Uses Of Cyclodextrin And Cyclodextrin In Combination With Vitamin E For The Treatment Of All Lysosomal Storage Diseases US CON 15/620,753 1102-04-22 Issued PDF
NINDS E-143-2002-1-EP-49 Method For the Treatment of Multiple Sclerosis EP DIV 17175522.6 Abandoned
NCI E-184-2018-0-HU-01 Methods For Diagnosing Breast Cancer HU ORD P1700254 Pending
NCI E-184-2018-1-HU-01 Methods For Diagnosing Breast Cancer HU ORD P1700255 Pending
NCI E-021-2015-0-JP-07 Anti-CD70 Chimeric Antigen Receptors JP National Stage 2017-530742 Issued
CC E-114-2016-0-PCT-02 TISSUE CHARACTERIZATION WITH ACOUSTIC WAVE TOMOSYNTHESIS PCT PCT PCT/US17/036599 Expired
NCI E-248-2016-0-US-04 Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer US National Stage 15/534,203 Abandoned
CC E-109-2017-0-US-01 PROGRESSIVE AND MULTI-PATH HOLISTICALLY NESTED NETWORKS FOR SEGMENTATION US 62/516,948 Abandoned
NCI E-021-2015-0-CN-05 Anti-CD70 Chimeric Antigen Receptors CN National Stage 201580066498.4 Issued
NIBIB E-005-2012-3-US-01 Multi-Focal Structured Illumination Microscopy Systems and Methods US CIP 15/614,766 10025082 Issued PDF
NCI E-167-2016-0-PCT-02 Fully Human Antibody Targeting PD1 For Cancer Immunotherapy PCT PCT PCT/US17/036200 Abandoned
NHGRI E-110-2017-0-US-01 METHODS OF DETECTING AND TREATING GATM-RELATED RENAL DISORDERS US 62/515,834 Abandoned
CC E-182-2016-0-PCT-02 SPATIAL AGGREGATION OF HOLISTICALLY-NESTED CONVOLUTIONAL NEURAL NETWORKS FOR AUTOMATED ORGAN LOCALIZATION AND SEGMENTATION IN 3D MEDICAL SCANS PCT PCT PCT/US17/035974 Expired
NCI E-107-2017-0-US-01 T CELLS MODIFIED TO OVEREXPRESS PHF19 US 62/515,105 Abandoned
NIAID E-051-2012-3-US-09 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US DIV 15/612,846 10035844 Issued PDF
NCI E-050-2014-0-HK-10 Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon HK CN 17105504.9 Pending
CC E-102-2017-1-US-01 DETECTION OF RADIOLOGY IMAGE FINDINGS USING LARGE-SCALE CLINICAL LESION ANNOTATIONS US 62/514,223 Abandoned
NIBIB E-005-2012-2-US-06 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US DIV 15/610,906 10042149 Issued PDF
NCI E-261-2016-0-EP-03 Compositions And Methods Of Diazeniumdiolate-based Prodrugs For Treating Cancer EP National Stage 15857037.4 Abandoned
NIBIB E-062-2017-0-US-01 SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING US 62/513,519 Abandoned
NIDCR E-152-2017-0-US-01 FORMATION OF STABLE CARTILAGE US 62/513,874 Abandoned
NCI E-169-2017-0-US-01 Inhibitors Of Endosomal Viral Membrane Fusion And Uses Thereof US 62/513,222 Abandoned
CC E-102-2017-0-US-01 DETECTION OF RADIOLOGY IMAGE FINDINGS USING LARGE-SCALE CLINICAL
LESION ANNOTATIONS 		US 62/513,179 Abandoned
NCI E-021-2015-0-US-08 ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS US National Stage 15/531,626 10689456 Issued PDF
NCATS E-148-2012-0-US-09 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS US CON 15/608,753 10370348 Issued PDF
NCI E-074-2017-0-US-01 ENGINEERED BACTERIOPHAGE WITH DUAL TAIL FIBERS THAT TARGETS NON-NATIVE PATHOGENIC HOST US 62/512,608 Abandoned
NIA E-279-2013-0-HK-07 METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS HK EP 17105381.7 Pending
NIAID E-042-2018-0-US-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE US 62/512,111 Abandoned
NCI E-148-2011-0-CN-13 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CN DIV 201710395649.1 Issued
NCATS E-276-2011-0-US-08 COMPOUNDS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS US CON 15/606,740 10301314 Issued PDF
NIDDK E-121-2019-0-US-02 METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE US ORD 15/607,379 10016432 Issued PDF
NIDDK E-121-2019-1-PCT-01 METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE PCT PCT COMB PCT/US2017/034865 Expired
NCI E-133-2016-0-PCT-02 FLT3-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME PCT PCT PCT/US17/034691 Expired
NCI E-133-2016-0-CA-07 FLT3-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME CA National Stage 3025516 Pending
NCI E-098-2017-0-US-01 TDP1 Use For Treatment of Cancer US 62/511,608 Abandoned
NCI E-250-2014-0-JP-07 Anti-CD276 Polypeptides and Proteins JP DIV 2017-103551 Issued
NICHD E-008-2015-0-US-03 DETERMINATION OF A JOINT PROBABILITY DISTRIBUTION OF RADIUS AND LENGTH OF ANISOTROPIC PORES FROM DOUBLE PULSED FIELD GRADIENT MRI DATA US National Stage 15/529,412 10871539 Issued PDF
NHLBI E-218-2016-0-PCT-02 Immunogens, Compositions, And Methods For Treating Dyslipidemia PCT PCT PCT/US2017/034149 Expired